Page 1 | Search Results | Hematology, ASH Education Program

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Novel agents and immune invasion in Hodgkin lymphoma

Reid W. Merryman, Ann LaCasce

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 243–248.

https://doi.org/10.1182/hematology.2019000029

Published: 2019

Journal Articles

Treatment of primary immunodeficiency with allogeneic transplant and gene therapy

Sung-Yun Pai

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 457–465.

https://doi.org/10.1182/hematology.2019000052

Published: 2019

Journal Articles

Novel therapies for relapsed/refractory aggressive lymphomas

Jonathon B. Cohen

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 75–82.

https://doi.org/10.1182/asheducation-2018.1.75

Published: 2018

Journal Articles

Extracorporeal photopheresis: cellular therapy for the treatment of acute and chronic graft-versus-host disease

Jennifer Schneiderman

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 639–644.

https://doi.org/10.1182/asheducation-2017.1.639

Published: 2017

Journal Articles

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Andrew C. Dietz, Alan S. Wayne

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 708–715.

https://doi.org/10.1182/asheducation-2017.1.708

Published: 2017

Journal Articles

Can selectin and iNKT cell therapies meet the needs of people with sickle cell disease?

Joshua J. Field

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 426–432.

https://doi.org/10.1182/asheducation-2015.1.426

Published: 2015

Journal Articles

Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen

Renier J. Brentjens, Kevin J. Curran

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 143–151.

https://doi.org/10.1182/asheducation.V2012.1.143.3798224

Published: 2012

Journal Articles

Towards the Generation of Patient-Specific Pluripotent Stem Cells for Combined Gene and Cell Therapy of Hematologic Disorders

George Q. Daley

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 17–22.

https://doi.org/10.1182/asheducation-2007.1.17

Published: 2007

NARROW

Novel agents and immune invasion in Hodgkin lymphoma

Treatment of primary immunodeficiency with allogeneic transplant and gene therapy

Novel therapies for relapsed/refractory aggressive lymphomas

Extracorporeal photopheresis: cellular therapy for the treatment of acute and chronic graft-versus-host disease

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Can selectin and iNKT cell therapies meet the needs of people with sickle cell disease?

Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen

Towards the Generation of Patient-Specific Pluripotent Stem Cells for Combined Gene and Cell Therapy of Hematologic Disorders

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only